4 Intraday Stocks for Monday Morning: Stocks watchlist - Sun Pharma, Bajaj Finance, Nestle India and BPCL

Calling all Intraday traders! Buckle up for a potentially volatile Monday session, as the market prepares for a new week. Here are 4 diverse stocks that could be in for an exciting ride:

1. Sun Pharma: This pharmaceutical giant is coming off a period of consolidation. A decisive breakout above key resistance could trigger a bullish rally, fueled by its strong product pipeline and presence in emerging markets. Keep an eye on global pharma news and sector sentiment for entry cues.

2. Bajaj Finance: This NBFC leader has been on a tear lately, but can it maintain momentum? A close above a crucial level could send it soaring further, driven by its diversified financial services offerings and strong loan growth. Watch for volume confirmation and overall market sentiment for trading signals.

Also Read4 Intraday Stocks to watch for Tomorrow 02 February 2024 - TATA CONSUMER, OBEROI REALTY, PEL and VOLTAS

3. Nestle India: This FMCG giant might see increased volatility due to potential news or sector trends. A breakout above resistance could signal positive sentiment, while a dip below support might indicate profit booking. Track news flow and technical indicators for entry decisions.

4. BPCL: This energy player could see renewed interest amidst fluctuating oil prices. A close above a key resistance level could trigger buying, fueled by potential government initiatives or sector developments. Track oil price movements and industry news for trading signals.

Remember, the intraday battlefield demands agility and discipline. Always conduct your own research, utilize stop-loss orders, and stick to your trading plan. Stay calm amidst the market frenzy, and don't let emotions cloud your judgment.

Disclaimer: This article is for informational purposes only and should not be considered financial advice. Please consult with a qualified financial advisor before making any investment decisions.

Don't Spam in Comment's !!

Post a Comment (0)
Previous Post Next Post